Transform Clinical Trial Recruitment with AI
Join leading sponsors using our physician-developed AI to accelerate trial enrollment, reduce screen failures, and cut recruitment costs by millions.
4000+
Charts processed per month
97.1%
Overall accuracy
$8M+
Saved from avoided delays
8+
Active trials
The Clinical Trial Recruitment Crisis
85% of clinical trials face enrollment delays. Tufts CSDD studies show daily opportunity costs of $500K-$800K in unrealized drug revenues. A 5-month recruitment delay can result in $90M revenue loss.
Slow Manual Review
Chart review takes hours per patient, creating bottlenecks that delay enrollment
High Screen Failures
Inconsistent screening leads to expensive failures and regulatory delays
Budget Overruns
Mid-trial amendments due to poor recruitment waste millions in development costs
Missed Timelines
Recruitment delays push back market entry and competitive advantage
Retina Intelligence: Real-Time AI Patient Screening
Our physician-developed AI engine analyzes unstructured clinical notes and imaging to identify trial-eligible patients instantly.
Real-Time EHR Analysis
AI reads and understands unstructured clinical notes, imaging reports, and lab values as physicians document care
Multi-Trial Screening
Simultaneously evaluate patients against multiple trial protocols, maximizing enrollment opportunities
HIPAA-Compliant Security
Enterprise-grade security with role-based access controls and cloud-native architecture
Powered by Retina Intelligence Engine
Our physician-developed AI is trained on diverse clinical scenarios and seamlessly integrates with your trial workflows.
Clinical Trial Recruitment Accelerator
Identify eligible patients in real-time as clinical data is documented. Never miss an eligible patient again and 2x recruitment speed.
Multi-Protocol Screening
Simultaneously evaluate patients against multiple trial protocols, maximizing enrollment opportunities and optimizing site efficiency.
Predictive Analytics
Advanced analytics provide enrollment forecasting and site performance insights to optimize trial planning and execution.
Physician-Led Development
Cosign AI is powered by our Retina Intelligence engine, trained by retina specialists on diverse clinical circumstances. Our solutions seamlessly integrate with your trial workflows and clinical practice.
Proven Results in Real-World Clinical Settings
Published evidence from Retinal Diagnostic Center across 728 consecutive patient records.
728
Consecutive Patients
Single-site validation study
97.1%
Overall Accuracy
Across 3 AMD trial protocols
167
Seconds Per Patient
Average processing time
Published Research
Retina Society 2025: "Feasibility of AI-Assisted Screening for Clinical Trials in Wet Age-Related Macular Degeneration"
728 consecutive patients from etinal Diagnostic Center across LUGANO/LUCIA, ASCENT, and CONSTANCE trials.
View Full StudyTrial-Specific Performance
CONSTANCE: 98.8% accuracy, 100% sensitivity
ASCENT: 96.6% accuracy, 83.3% sensitivity
LUGANO: 95.8% accuracy, 80.7% sensitivity
Enterprise-Grade AI Technology
Built by physicians for pharmaceutical-grade security, compliance, and scalability.
HIPAA Compliance
Enterprise-grade encryption and audit trails
Cloud-Native Architecture
Scalable infrastructure on Google Cloud and Microsoft Azure platforms
EHR Integration
Seamless integration with Epic, Athena, Nextech, and other major EHR systems
Role-Based Access
Granular permissions for sponsors, CROs, sites, and investigators
Advanced NLP
Understands complex medical terminology and unstructured clinical notes
Real-Time Processing
Instant analysis as clinical data is entered into EHR systems